Adipose tissue and the adipocyte: Review;Yaǧ dokusu ve yaǧ hücresi

Turkiye Klinikleri Journal of Medical Sciences

Volumn 25, Issue 3, 2005, Pages 412-420

  Ergün, Ahmet ^a  

^a ANKARA UNIVERSITY   (Turkey)

Author keywords

Adipocytes; Adiponectin; Adipose tissue; Angiotensinogen; Interleukin 6; Leptin; Viperidae

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADIPONECTIN; ADIPSIN; ANGIOTENSIN; ANGIOTENSINOGEN; CATECHOLAMINE; GLUCOCORTICOID; GROWTH HORMONE; INSULIN; INSULIN RECEPTOR; INTERLEUKIN 6; LEPTIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROSTACYCLIN; PROSTAGLANDIN F2 ALPHA; RESISTIN; SOMATOMEDIN C; TRANSFORMING GROWTH FACTOR BETA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ACID SECRETION; ADIPOCYTE; ADIPOSE TISSUE; ADIPOSE TISSUE METABOLISM; APOPTOSIS; BLOOD CLOTTING; BLOOD PRESSURE REGULATION; CELL DIFFERENTIATION; CELL PROLIFERATION; ELECTROLYTE BALANCE; ENDOCRINE GLAND; ENERGY METABOLISM; FAMILIAL COMBINED HYPERLIPIDEMIA; FAMILIAL DISEASE; FEEDBACK SYSTEM; FIBRINOLYSIS; GLUCOSE METABOLISM; HORMONAL REGULATION; HOST RESISTANCE; HUMAN; HYPERLIPIDEMIA; INFLAMMATION; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID METABOLISM; LIPOGENESIS; MENSTRUATION; NONHUMAN; OBESITY; OVULATION; PROTEIN FUNCTION; REVIEW; WHITE ADIPOSE TISSUE;

EID: 21344470340     PISSN: 13000292     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (33)

1. Schling P, Löffler G. Cross talk between adipose tissue cell, impact on pathophysiology. News Physiol Sci 2002; 17:99-104.
2. Wickelgren I. Obesity: How big a problem? Science 1998; 280:1364-7.
3. Goldstein BJ. Insulin resistance as the care defect in type 2 diabetes mellitus. Am J Cardiol 2002;90(Suppl):3G-10G.
4. Lopez F. Pharmacological treatment of obesity. Drugs 2002;62:915-44.
5. Ergün A. Leptin (ob Protein). Turkiye Klinikleri J Med Sci 1999;19:130-6.
6. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Tren Endoc & Metab 2002;13:18-23.
7. Fruhbeck G, Gomez-Ambrosi J, Muruzabal FC, Burrell MA. The adipocyte: A model for integration of endocrine and metabolic signaling in energy metabolsm regulation. Am J Physiol Endocrinol Metab 2001;280:E827-E847.
8. Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV. Leptin: The tale of an obesity gene. Diabetes 1996;45:1455-62.
9. Montague CT, O'Rahilly S. Causes and consequences of visceral adiposity. Diabetes 2000;49:883-8.
10. Miller WH, Faust IM, Goldberger AC, Hirsch J. Effects of severe long-term food deprivation and refeeding on adipose tissue cells in the rat. Am J Pysiol 1983;245:E74-E80.
11. Fried SK, Bunkin DA, Greenberg AS. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: Depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 1998;83:847-50.
12. Reynisdottir S, Dauzats M, Thorne A, Langin D. Comparison of hormone-sensitive lipase activity in visceral and subcutaneous human adipose tissue. J Clin Endocrinol Metab 1997;82:4162-6.
13. th ed. London: Churchill Livingstone; 2000. p.73-4.
14. Warden NAS, Warden CH. Biological influences on obesity. Pediatric Clinics of North America 2001;48:879-91.
15. Mohamed-Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6 but not tumor necrosis factor-α, in vivo. J Clin Endocrinol Metab 1997;82:4196-200.
16. Wiecek A, Kokot F, Chudek J, Adamczak M. The adipose tissue a novel endocrine organ of interest to the nephrologist. Nephrol Dial Transplant 2002;17:191-5.
17. Berger A. Resistin: A new hormone that links obesity with type 2 diabetes. BMJ 2001;322:193.
18. Ling C, Kindblom J, Wennbo H, Billig H. Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels. FEBS Lett 2001;507:147-50.
19. Fasshauer M, Klein J, Neumann S, Eszlinger M, Paschke R. Isoproterenol inhibits resistin gene expression through a G(S)-protein-coupled pathway in 3T3-L1 adipocytes. FEBS Lett 2001;500:60-3.
20. Shojima N, Sakoda H, Ogihara T, et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes 2002;51:1737-44.
21. Haugen F, Jorgensen A, Drevon CA, Trayhum P. Inhibition by insulin of resistin gene expression in 3T3-L1 adipocytes. FEBS Lett 2001;507:105-8.
22. Shuldiner AR, Yang R, Gong DW. Resistin, obesity, and insulin resistance the emerging role of the adipocyte as an endocrine organ. N Engl J Med 2001;345:1345-6.
23. Stumvoll M, Haring H. The peroxisome proliferator-activated receptor-γ2 pro 12A1a polymorphism. Diabetes 2002;51:2341-7.
24. Savage DB, Sewter CP, Klenk ES, et al. Resistin/Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-γ action in humans. Diabetes 2001;50:2199-202.
25. Gülle K, Karagöz E. Leptinler. Turkiye Klinikleri J Med Sci 2000;20:112-21.
26. Juan CC, Au LC, Fang VS, et al. Suppressed gene expression of adipocyte resistin in an insulin-resistant rat model probably by elevated free fatty acids. Biochem Biophys Res Commun 2001;289:1328-33.
27. Spiegelman BM. Obesity and the regulation of energy balance. Cell 2001;104:531-43.
28. Baskin DG, Breininger JF, Schwartz MW. Leptin receptor mRNA identifies a subpopulation of neuropeptide Y neurons activated by fasting in rat hypothalamus. Diabetes 1999;48:823-33.
29. Friedman JM, Halaas J. Leptin and the regulation of body weight in mammals. Nature 1998;395:763-70.
30. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996;382:250-2.
31. Steppan CM, Bailey ST, Bhat S, et al. The hormone resistin links obesity to diabetes. Nature 2001;409:307-12.
32. Prins J B, Neisler CU, Winterford CM, et al. Tumor necrosis factor-α induces apoptosis of human adipose cells. Diabetes 1997;46:1939-44.
33. Ergün A. Yaǧ hücresinden salgilanan maddeler, resistin ve insülin direnci. Ankara Üniversitesi Tip Fakültesi Mecmuasi 2003;56:25-30.